Flanders Medical Research Program
25
0
0
21
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
4.0%
1 terminated/withdrawn out of 25 trials
95.5%
+8.9% vs industry average
60%
15 trials in Phase 3/4
0%
0 of 21 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (25)
In.Pact Flexion, Investigating the Performance of the In.Pact Admiral DEB for Popliteal Lesions
Role: lead
REFLOW Study, Investigating the Efficacy of the LEGFLOW DCB in TASC C&D Fempop Lesions
Role: lead
a Physician-inititated Trial Investigating the iVolution Nitinol Stent
Role: lead
Physician-Initiated Trial Investigating the Efficacy of Endovascular Treatment of Femoropopliteal Arterial Stenotic Disease With the Biotronik Passeo-18 Lux Drug Releasing Balloon and the Biotronik Pulsar-18 Stent (Comparing With 4EVER Trial Results)
Role: lead
The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery for the Treatment The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery of Femoropopliteal TASC C&D Lesions
Role: lead
Prospective, Non-randomized Multi-center, Controlled Physician-initiated Trial: Rotarex Belgium In-stent Occlusion
Role: lead
Clear-Road Trial, Investigating the Efficacy of the RoadSaver Stent
Role: lead
BeSmooth Study, Investigating the BeSmooth Peripheral Stent System for the Treatment of Iliac Lesions
Role: lead
Physician-Initiated Trial Investigating the BeGraft Peripheral Stent Graft System
Role: lead
NanoCross BTK, a Prospective, Non-randomized, Multicenter, Controlled Trial Evaluating the Performance of the NanoCrossTM .014 Balloon Catheter in Infrapopliteal Lesions
Role: lead
PREVENT: Promus BTK
Role: lead
EXCimEr Laser for Long lENgTh Lesions in Below-The-Knee Arteries Study
Role: lead
Drug Eluting Stents In The Critically Ischemic Lower Leg 2
Role: lead
Single Arm Study With a Nitinol Self-Expanding Paclitaxel-Eluting Stent to Treat BTK Arteries
Role: lead
GORE VIABAHN® Versus Plain Old Balloon Angioplasty (POBA) for Superficial Femoral Artery (SFA) In-Stent Restenosis
Role: lead
Misago Iliac Study
Role: lead
DURABILITY+ : a Prospective, Multi-center, Controlled Study With the Everflex+ Stent in SFA Lesions
Role: lead
Efficacity Study With the Protégé EverFlex Stent in Popliteal Lesions
Role: lead
4-EVER : a Trial Investigating the Safety of 4F Endovascular Treatment of Infra-Inguinal Arterial Stenotic Disease
Role: lead
Efficacy Study of Iliac Stents to Treat TASC A-B-C-D Iliac Artery Lesions
Role: lead